Skip to main content
. 2024 Dec 3;387:e080439. doi: 10.1136/bmj-2024-080439

Table 3.

Main results for analysis of primary, safety, and secondary outcomes. Values are number (percentage) unless stated otherwise

No included in analysis Summary measure Fully adjusted prespecified primary analysis model Minimally adjusted analysis model (post hoc)*
Intervention (n=1251) Usual Care (n=1247) Intervention Usual Care Adjusted odds ratio (95% CI) P value Adjusted difference in percentage points (95% CI) Adjusted odds ratio (95% CI) P value Adjusted difference in percentage points (95% CI)
Postoperative infection <30 days of randomisation (primary outcome) 1247 (99.7) 1247 (100) 289 (23.2) 283 (22.7) 1.03 (0.84 to 1.25) 0.81 0.4 (−3.4 to 4.2) 1.03 (0.85 to 1.25) 0.75 0.5 (−3.3 to 4.3)
Acute cardiac event <24 hours of randomisation (safety outcome) 1250 (99.9) 1247 (100) 38 (3.0) 21 (1.7) 1.82 (1.06 to 3.13) 0.03 1.3 (0.1 to 2.5) 1.84 (1.07 to 3.17) 0.03 1.4 (0.0 to 2.7)
Acute cardiac event <30 days of randomisation (safety outcome) 1249 (99.8) 1247 (100) 85 (6.8) 79 (6.3) 1.06 (0.77 to 1.47) 0.71 0.4 (−1.6 to 2.3) 1.09 (0.79 to 1.50) 0.61 0.5 (−1.4 to 2.4)
Acute kidney injury <30 days of randomisation 1250 (99.9) 1247 (100) 40 (3.2) 32 (2.6) 1.24 (0.77 to 2.00) 0.37 0.6 (−1.1 to 2.3) 1.26 (0.78 to 2.02) 0.35 0.6 (−1.1 to 2.3)
Mortality <180 days of randomisation 1241 (99.2) 1239 (99.4) 68 (5.4) 84 (6.7) 0.76 (0.54 to 1.07) 0.12 −1.5 (−3.5 to 0.5) 0.79 (0.56 to 1.11) 0.17 −1.3 (−3.1 to 0.6)

ASA=American Society of Anesthesiologists.

*

Adjusted for minimisation factors: country, surgical procedure, and ASA class only.